Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine

This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.

Detalles Bibliográficos
Autores principales: Richards, Nathan E., Keshavarz, Behnam, Workman, Lisa J., Nelson, Michael R., Platts-Mills, Thomas A. E., Wilson, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414189/
https://www.ncbi.nlm.nih.gov/pubmed/34473262
http://dx.doi.org/10.1001/jamanetworkopen.2021.24331
_version_ 1783747761906122752
author Richards, Nathan E.
Keshavarz, Behnam
Workman, Lisa J.
Nelson, Michael R.
Platts-Mills, Thomas A. E.
Wilson, Jeffrey M.
author_facet Richards, Nathan E.
Keshavarz, Behnam
Workman, Lisa J.
Nelson, Michael R.
Platts-Mills, Thomas A. E.
Wilson, Jeffrey M.
author_sort Richards, Nathan E.
collection PubMed
description This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered.
format Online
Article
Text
id pubmed-8414189
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-84141892021-09-22 Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine Richards, Nathan E. Keshavarz, Behnam Workman, Lisa J. Nelson, Michael R. Platts-Mills, Thomas A. E. Wilson, Jeffrey M. JAMA Netw Open Research Letter This cohort study compares antibody responses in a cohort in which both BNT162b2 and mRNA-1273 COVID-19 vaccines were administered. American Medical Association 2021-09-02 /pmc/articles/PMC8414189/ /pubmed/34473262 http://dx.doi.org/10.1001/jamanetworkopen.2021.24331 Text en Copyright 2021 Richards NE et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Richards, Nathan E.
Keshavarz, Behnam
Workman, Lisa J.
Nelson, Michael R.
Platts-Mills, Thomas A. E.
Wilson, Jeffrey M.
Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title_full Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title_fullStr Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title_full_unstemmed Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title_short Comparison of SARS-CoV-2 Antibody Response by Age Among Recipients of the BNT162b2 vs the mRNA-1273 Vaccine
title_sort comparison of sars-cov-2 antibody response by age among recipients of the bnt162b2 vs the mrna-1273 vaccine
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414189/
https://www.ncbi.nlm.nih.gov/pubmed/34473262
http://dx.doi.org/10.1001/jamanetworkopen.2021.24331
work_keys_str_mv AT richardsnathane comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine
AT keshavarzbehnam comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine
AT workmanlisaj comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine
AT nelsonmichaelr comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine
AT plattsmillsthomasae comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine
AT wilsonjeffreym comparisonofsarscov2antibodyresponsebyageamongrecipientsofthebnt162b2vsthemrna1273vaccine

Ejemplares similares